Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14420
Articles
Company
Drug
YiChang HEC ChangJiang Pharma’s Insulin Aspart Gains NMPA Approval
February 2, 2025
Company
Drug
Henlius Biotech’s Hanbeitai Gains NMPA Approval for Recurrent Glioblastoma
February 2, 2025
Company
Policy / Regulatory
NHSA Responds to Proposal on Dental Implants’ Inclusion in NRDL
February 2, 2025
Company
Johnson & Johnson Reports Q3 Sales Growth, Maintains Full-Year Guidance
February 2, 2025
Company
Deals
Sichuan Biokin Pharma Plans IPO on STAR Board to Raise RMB 1.422 Billion
February 2, 2025
Company
Drug
Mabwell Bioscience’s 9MW3011 Accepted for Review by China’s NMPA
February 2, 2025
Company
Drug
Zhiyi Biotechnology Receives FDA Clearance for SK10 in Chemotherapy-Induced Diarrhea
February 2, 2025
Company
Deals
Shanghai’s Hrain Biotechnology Plans IPO on STAR Board to Raise RMB 2.539 Billion
February 2, 2025
Company
Deals
Eucure Biopharma Partners with Syncromune on Intratumoral Immunotherapy
February 3, 2025
Company
Drug
Abogen Biosciences Receives UAE Clinical Trial Approval for Omicron BA.4/5 mRNA Vaccine
February 2, 2025
Company
Deals
Shenzhen GeneBioHealth Secures USD 15M for Bio-Business Expansion
February 3, 2025
Company
Drug
CSPC’s Generic Xofluza Gains NMPA Approval Amid Roche Patent Dispute
February 3, 2025
1
2
…
1,114
1,115
1,116
1,117
1,118
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
